Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Beta-cell Autoimmunity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00515099
What this trial is testing

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

Who this might be right for
New-onset Type 1 Diabetes Mellitus
National Institute of Allergy and Infectious Diseases (NIAID) 58
Not applicableStudy completedNCT01176253
What this trial is testing

Detection of Human Beta Cell Death in Type 1 Diabetes Mellitus (T1DM) by Methylation Specific Polymerase Chain Reaction (PCR)

Who this might be right for
Type 1 Diabetes Mellitus
City of Hope Medical Center 6
Not applicableLooking for participantsNCT05899166
What this trial is testing

Carbohydrate Beta Cell Function and Glucose Control in Children With Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Boston Children's Hospital 52
Testing effectiveness (Phase 2)Looking for participantsNCT06524960
What this trial is testing

Denosumab for Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
City of Hope Medical Center 45
Not applicableStudy completedNCT00357890
What this trial is testing

Insulin Pump Therapy in Adolescents With Newly Diagnosed Type 1 Diabetes (T1D)

Who this might be right for
Diabetes Mellitus, Insulin-Dependent
Nemours Children's Clinic 12
Not applicableLooking for participantsNCT00001350
What this trial is testing

Study of Autoimmune Lymphoproliferative Syndrome (ALPS)

Who this might be right for
Benign Lymphoproliferative Disorder
National Institute of Allergy and Infectious Diseases (NIAID) 1,200
Not applicableLooking for participantsNCT04528355
What this trial is testing

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+2 more
Paul Szabolcs 50
Not applicableActive Not RecruitingNCT06832215
What this trial is testing

Urine Extracellular Vesicles: Non-invasive Biomarkers of Β-cell Function and Novel Therapeutic Agents in Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus
Unidade Local de Saúde de Coimbra, EPE 120
Testing effectiveness (Phase 2)Looking for participantsNCT01962415
What this trial is testing

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more
Paul Szabolcs 100
Testing effectiveness (Phase 2)Ended earlyNCT04899271
What this trial is testing

Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.

Who this might be right for
New-onset Type 1 Diabetes
Dompé Farmaceutici S.p.A 25
Testing effectiveness (Phase 2)Study completedNCT02846545
What this trial is testing

SIMPONI® to Arrest Beta-cell Loss in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Janssen Research & Development, LLC 84
Early research (Phase 1)Ended earlyNCT00974740
What this trial is testing

DIATOR-Diabetes Intervention With Atorvastatin

Who this might be right for
Type 1 Diabetes
Profil Institut für Stoffwechselforschung GmbH 63
Not applicableStudy completedNCT04375020
What this trial is testing

GABA and Beta-cell Regeneration

Who this might be right for
Diabetes Mellitus, Type 1
Ministry of Health and Population, Egypt 100
Not applicableStudy completedNCT05616273
What this trial is testing

Stimulated Glucagon as a Biomarker of Hypoglycemic Risk in Type 1 Diabetes

Who this might be right for
Type 1 DiabetesHypoglycemia
University of Exeter 62
Testing effectiveness (Phase 2)Study completedNCT00529191
What this trial is testing

Atorvastatin in New Onset Type 1 Diabetes Mellitus (T1DM)

Who this might be right for
Type 1 Diabetes
Children's Hospital of Philadelphia 40
Testing effectiveness (Phase 2)Study completedNCT01155284
What this trial is testing

Combination Therapy With Sitagliptin and Lansoprazole to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Sanford Health 70
Testing effectiveness (Phase 2)Study completedNCT00768651
What this trial is testing

Incretin Effect and Use After Clinical Islet Transplantation

Who this might be right for
Type 1 Diabetes
University of Alberta 8
Large-scale testing (Phase 3)Looking for participantsNCT07258394
What this trial is testing

Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes
Nanjing Medical University 90
Not applicableUnknownNCT05290688
What this trial is testing

Cellular microRNA Signatures in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Institut Pasteur 20
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Next Page